The Lancet Microbe
9 papers8 directions
The Lancet Microbe is a clinical microbiology journal that has published research at the intersection of microbiology and computational science since 2021. In the context of machine learning and artificial intelligence, the venue serves as a platform for studies that utilize data-driven approaches to address infectious disease challenges. Research published here often involves the application of genomic and phenogenomic analysis to understand pathogen behavior, antimicrobial resistance, and treatment outcomes.
The venue's contributions to the computational field include the use of in-silico data analysis and causal discovery methods, particularly within the study of the microbiome. A significant portion of the work focuses on identifying genetic determinants of resistance in Mycobacterium tuberculosis and analyzing nosocomial bacterial pathogens through deep sequencing. Other research directions include target trial emulation to study hybrid immunity in viral infections like SARS-CoV-2 and the development of genotypic catalogues for drug resistance.
Active contributors to the journal include researchers such as Derrick W. Crook, Zamin Iqbal, and Jukka Corander, who frequently employ large-scale genotypic and phenotypic datasets. By hosting studies that integrate clinical data with computational modeling, The Lancet Microbe facilitates the application of data science techniques to predict drug resistance and identify bacterial determinants in clinical strains. Its role in the research community is defined by this synthesis of microbiology with modern computational methodologies.
Papers by Year
| 2024 | 4 |
| 2023 | 2 |
| 2022 | 2 |
| 2021 | 1 |
Top Research Directions
Research directions most represented by papers from this venue.
Top Authors
| Author | Papers |
|---|---|
| Antti Honkela | 1 |
| Elizabeth Stuart | 1 |
Impactful Papers
Papers from this venue that shaped research clusters.